(Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (Q4)Nov 30, 2023 | |
---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||
Cash flow from continuing operating activities | -9.3K | -9.44K | -40.18K | -17.77K |
Net income from continuing operations | ---78.22K | ---32.19K | ---53.54K | --7.47K |
Remuneration paid in stock | --0 | --0 | --42.1K | ---- |
Deferred tax | ---- | ---- | ---- | --11K |
Other non cashItems | ---- | ---- | ---- | ---60K |
Change In working capital | --68.92K | --22.75K | ---28.75K | --23.76K |
-Change in receivables | ---3.66K | ---323 | ---4.5K | ---1.29K |
-Change in prepaid assets | ---- | --0 | ---27.5K | ---4.5K |
-Change in payables and accrued expense | --45.08K | --23.07K | --3.25K | --29.55K |
Cash from discontinued investing activities | ||||
Operating cash flow | ---9.3K | ---9.44K | ---40.18K | ---17.77K |
Investing cash flow | ||||
Cash flow from continuing investing activities | 0 | 0 | -44.58K | -75.5K |
Net PPE purchase and sale | --0 | --0 | ---44.58K | ---75.5K |
Cash from discontinued investing activities | ||||
Investing cash flow | --0 | --0 | ---44.58K | ---75.5K |
Financing cash flow | ||||
Cash flow from continuing financing activities | -27.5K | 0 | 20K | 217.75K |
Net common stock issuance | --0 | --0 | --20K | --217.75K |
Cash from discontinued financing activities | ||||
Financing cash flow | ---27.5K | --0 | --20K | --217.75K |
Net cash flow | ||||
Beginning cash position | --50.28K | --59.72K | --124.48K | --0 |
Current changes in cash | ---36.8K | ---9.44K | ---64.77K | --124.48K |
End cash Position | --13.47K | --50.28K | --59.72K | --124.48K |
Free cash from | ---9.3K | ---9.44K | ---84.77K | ---93.27K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data